54 substances should be contraindicated, KFDA says

Published: 2010-11-04 06:57:00

Updated: 2010-11-04 06:57:00

The Korea Food and Drug Administration announced on November 2 that it designated a total of 54 ingredients that cannot co-administered with others during doctor’s prescription or that has safety problems and age limitations, as part of efforts to promote patient safety by an increased review and...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK